Latest news with #DKK511.40

Business Insider

Kepler Capital Remains a Hold on Novonesis (0Q4U)

In a report released on June 25, Patrick Roquas from Kepler Capital maintained a Hold rating on Novonesis (0Q4U – Research Report), with a price target of DKK450.00. The company's shares closed last Wednesday at DKK467.09. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Roquas is ranked #4038 out of 9622 analysts. Novonesis has an analyst consensus of Strong Buy, with a price target consensus of DKK511.40. Based on Novonesis' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of DKK1.08 billion and a net profit of DKK186 million. In comparison, last year the company earned a revenue of DKK6.83 billion and had a net profit of DKK238.33 million